Ovid Therapeutics
OVID
#9225
Rank
โ‚น5.74 B
Marketcap
โ‚น80.85
Share price
-4.94%
Change (1 day)
-71.33%
Change (1 year)

Ovid Therapeutics (OVID) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น5.33 Billion

According to Ovid Therapeutics 's latest financial reports the company has โ‚น5.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ovid Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น8.81 B-17.46%
2022-12-31โ‚น10.67 B-23.63%
2021-12-31โ‚น13.97 B165.33%
2020-12-31โ‚น5.26 B-3.73%
2019-12-31โ‚น5.47 B88.58%
2018-12-31โ‚น2.90 B-47.84%
2017-12-31โ‚น5.56 B57.61%
2016-12-31โ‚น3.52 B-24.07%
2015-12-31โ‚น4.64 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น23.18 B 334.32%๐Ÿ‡บ๐Ÿ‡ธ USA